Vaccines Related News
WHO lists Pfizer/BioNTech COVID-19 vaccine for emergency use
As more countries across the globe begin rolling out their mass COVID-19 vaccination programmes, the World Health Organization (WHO) has now listed the Pfizer/BioNTech...
NHS needs more resources to vaccinate public effectively warns BMA
The BMA has warned the NHS will need more resources if it is to vaccinate the public effectively after a new survey has revealed...
Oxford University COVID-19 vaccine roll out begins
The first person in the UK has now received the Oxford University and AstraZeneca COVID-19 vaccine, which has begun its NHS roll out today.
The...
European Commission concludes Novavax talks for COVID-19 vaccine
The European Commission has concluded its talks with pharmaceutical company Novavax regarding the purchase of its potential COVID-19 vaccine.
The European Commission and Novavax envisaged...
Clinical trials for another COVID-19 vaccine begin in UK
Early Phase I and Phase II clinical trials have started in the UK for the Valneva COVID-19 vaccine, which is to be tested on...
Can vaccines truly bring COVID-19 under control?
In order to truly bring COVID-19 under control, vaccines must prevent infection, disease progression, and transmission, say experts.
In a new editorial published in the...
COVID-19 Oxford vaccine found safe and effective in Phase III trial
The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to protect against the virus.
The...
Meningococcus B vaccine shows 79% effectiveness
A vaccine for the deadly Meningococcus B has been shown to have 79% effectiveness in patients under the age of 18.
Meningococcus group B is...
Over half a million Brits participating in COVID-19 research
Over half a million British people have taken part in pioneering health research into COVID-19 over the last eight months.
The UK has been conducting...
COVID-19 vaccine added to damages scheme in case of severe disability
The UK has taken the precautionary measure of adding COVID-19 to its Vaccine Damage Payments Scheme so people will be able to access financial...
European Commission approves contract for potential COVID-19 vaccine
The European Commission has approved a contract with Moderna to secure access to a potential COVID-19 vaccine.
The contract will be the sixth one made...
Over 50s in UK to receive free flu vaccine
The UK Government has announced that citizens over 50 in the UK will be able to receive a free flu vaccine from 1 December...
Oxford COVID-19 vaccine shows promising results in older adults
Phase II of the Oxford vaccine trial has shown promising safety results in older adults, finding it provokes an immune response.
The early stage results,...
COVID-19 vaccine Phase III clinical trials to begin in UK
Phase III clinical trials for a COVID-19 vaccine are set to begin in the UK and will involve 6,000 volunteers from across the country.
Global...
Could COVID-19 mink spread lessen the effectiveness of a vaccine?
The European Centre for Disease Prevention and Control (ECDC), an agency of the European Union, has warned that the spread of COVID-19 from minks...
Jo’s Cervical Cancer Trust: cervical cancer in focus
Jo’s Cervical Cancer Trust Chief Executive Robert Music speaks to HEQ about cervical cancer screening, treatment, and research.
In the UK, around 3,200 new cases...
Parents advised to keep childhood vaccination appointments
Public Health England (PHE) is urging parents to keep vaccination appointments for their children during national COVID-19 restrictions.
Could COVID-19 lead to measles and polio epidemics?
UNICEF and the World Health Organization are calling for emergency action to avoid potential measles and polio epidemics as COVID-19 disrupts normal immunisation programmes.
The...
Fighting for what’s right: protecting the older population
The Secretary General of the International Federation on Ageing (IFA), Dr Jane M Barratt, spoke to Health Europa Quarterly about how COVID-19 is impacting...
The vaccine industry – meeting the challenges of COVID-19
Magdalena Rodriguez de Azero, Executive Director Vaccines Europe, discusses issues around vaccine provision, including supply and increased demand, as well as vaccine hesitancy in...